Market Tracker

07/28 4:37am ET

Immunomedics Inc (NASDAQ:IMMU)

8.55
Delayed Data
As of Jul 27
 -0.25 / -2.84%
Today’s Change
2.02
Today|||52-Week Range
9.51
+132.97%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close8.80
Today’s open8.81
Day’s range8.32 - 8.97
Volume1,298,601
Average volume (3 months)2,647,633
Market cap$970.3M
Dividend yield--
Data as of 07/27/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-73.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.46-1.45%
LNTHLantheus Holdings In...-0.30-1.56%
ALRPRBAlere Inc+0.16+0.04%
QDELQuidel Corp-1.26-3.38%
Data as of 07/27/2017

Financials

Next reporting dateAugust 24, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts